State Street Corp reduced its holdings in Intrexon Corporation (NYSE:XON) by 18.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,203,041 shares of the biotechnology company’s stock after selling 504,201 shares during the period. State Street Corp owned about 1.83% of Intrexon Corporation worth $53,071,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in XON. First Trust Advisors LP boosted its holdings in shares of Intrexon Corporation by 32.5% in the 2nd quarter. First Trust Advisors LP now owns 1,537,088 shares of the biotechnology company’s stock valued at $37,028,000 after acquiring an additional 376,780 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Intrexon Corporation by 5.6% in the 1st quarter. Vanguard Group Inc. now owns 4,286,362 shares of the biotechnology company’s stock valued at $84,954,000 after acquiring an additional 226,090 shares during the last quarter. Credit Suisse AG boosted its holdings in shares of Intrexon Corporation by 273.7% in the 1st quarter. Credit Suisse AG now owns 183,555 shares of the biotechnology company’s stock valued at $3,638,000 after acquiring an additional 134,434 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Intrexon Corporation by 60.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 144,428 shares of the biotechnology company’s stock valued at $2,862,000 after acquiring an additional 54,179 shares during the last quarter. Finally, Virtu KCG Holdings LLC purchased a new stake in shares of Intrexon Corporation in the 2nd quarter valued at $593,000. 82.23% of the stock is currently owned by institutional investors and hedge funds.

Intrexon Corporation (NYSE:XON) last posted its quarterly earnings data on Wednesday, August 9th. The biotechnology company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.05. Intrexon Corporation had a negative net margin of 60.63% and a negative return on equity of 19.08%. The firm had revenue of $54.40 million for the quarter, compared to analyst estimates of $57.17 million. During the same period last year, the firm posted ($0.42) EPS. Intrexon Corporation’s quarterly revenue was up 3.6% on a year-over-year basis.

Several analysts have recently commented on the stock. Northland Securities set a $30.00 price objective on shares of Intrexon Corporation and gave the company a “buy” rating in a report on Monday, August 7th. BidaskClub downgraded shares of Intrexon Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 22nd. Zacks Investment Research downgraded shares of Intrexon Corporation from a “hold” rating to a “sell” rating in a report on Monday, October 16th. JMP Securities reaffirmed an “outperform” rating and issued a $42.00 price objective on shares of Intrexon Corporation in a report on Thursday, October 5th. Finally, Griffin Securities reaffirmed a “buy” rating and issued a $55.00 price objective on shares of Intrexon Corporation in a report on Friday, October 6th. Two analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the stock. Intrexon Corporation has a consensus rating of “Hold” and a consensus target price of $43.20.

In other news, Director Dean J. Mitchell acquired 5,000 shares of the stock in a transaction that occurred on Friday, August 11th. The shares were purchased at an average cost of $18.33 per share, for a total transaction of $91,650.00. Following the transaction, the director now directly owns 18,103 shares in the company, valued at approximately $331,827.99. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert B. Shapiro acquired 2,850 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The stock was purchased at an average price of $17.50 per share, for a total transaction of $49,875.00. Following the completion of the transaction, the director now owns 43,157 shares in the company, valued at $755,247.50. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 144,569 shares of company stock worth $2,719,429. 55.10% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “State Street Corp Sells 504,201 Shares of Intrexon Corporation (XON)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/state-street-corp-sells-504201-shares-of-intrexon-corporation-xon/1675053.html.

Intrexon Corporation Profile

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).

Institutional Ownership by Quarter for Intrexon Corporation (NYSE:XON)

Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.